Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin
Infection by one of the 4 distinct serotypes of dengue virus (DENV) threatens >40% of the
world’s population, with no efficacious vaccine or antiviral agent currently available. DENV …
world’s population, with no efficacious vaccine or antiviral agent currently available. DENV …
A highly conserved transcriptional repressor controls a large regulon involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium tuberculosis
…, M Withers, CN Soffair, NJ Moreland… - Molecular …, 2007 - Wiley Online Library
The Mycobacterium tuberculosis TetR‐type regulator Rv3574 has been implicated in
pathogenesis as it is induced in vivo, and genome‐wide essentiality studies show it is required for …
pathogenesis as it is induced in vivo, and genome‐wide essentiality studies show it is required for …
[HTML][HTML] Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics
Group A Streptococcus (GAS; Streptococcus pyogenes) is a bacterial pathogen for which a
commercial vaccine for humans is not available. Employing the advantages of high-…
commercial vaccine for humans is not available. Employing the advantages of high-…
[HTML][HTML] Group A Streptococcus pharyngitis and pharyngeal carriage: a meta-analysis
…, E Malliya Wadu, N Pierse, NJ Moreland… - PLoS neglected …, 2018 - journals.plos.org
Objective Antibiotic treatment of Group A Streptococcus (GAS) pharyngitis is important in
acute rheumatic fever (ARF) prevention, however clinical guidelines for prescription vary. GAS …
acute rheumatic fever (ARF) prevention, however clinical guidelines for prescription vary. GAS …
[HTML][HTML] Status of research and development of vaccines for Streptococcus pyogenes
Streptococcus pyogenes is an important global pathogen, causing considerable morbidity
and mortality, especially in low and middle income countries where rheumatic heart disease …
and mortality, especially in low and middle income countries where rheumatic heart disease …
Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New Zealand
…, A Upton, JE Ussher, NJ Moreland - Clinical & …, 2021 - Wiley Online Library
Objectives Circulating antibodies are important markers of previous infection and immunity.
Questions remain with respect to the durability and functionality of SARS‐CoV‐2 antibodies. …
Questions remain with respect to the durability and functionality of SARS‐CoV‐2 antibodies. …
[HTML][HTML] Crystal structures of F420-dependent glucose-6-phosphate dehydrogenase FGD1 involved in the activation of the anti-tuberculosis drug candidate PA-824 …
The modified flavin coenzyme F 420 is found in a restricted number of microorganisms. It is
widely distributed in mycobacteria, however, where it is important in energy metabolism, and …
widely distributed in mycobacteria, however, where it is important in energy metabolism, and …
Preceding group A streptococcus skin and throat infections are individually associated with acute rheumatic fever: evidence from New Zealand
…, S Thomas, J Zhang, N Pierse, NJ Moreland… - BMJ Global …, 2021 - gh.bmj.com
Introduction Acute rheumatic fever (ARF) is usually considered a consequence of group A
streptococcus (GAS) pharyngitis, with GAS skin infections not considered a major trigger. The …
streptococcus (GAS) pharyngitis, with GAS skin infections not considered a major trigger. The …
[HTML][HTML] Risk factors for acute rheumatic fever: literature review and protocol for a case-control study in New Zealand
Acute rheumatic fever (ARF) and its sequela, rheumatic heart disease (RHD), have largely
disappeared from high-income countries. However, in New Zealand (NZ), rates remain …
disappeared from high-income countries. However, in New Zealand (NZ), rates remain …
[HTML][HTML] A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study
Background Streptococcus pyogenes is a leading cause of infection-related morbidity and
mortality. A reinvigorated vaccine development effort calls for new clinically relevant human S …
mortality. A reinvigorated vaccine development effort calls for new clinically relevant human S …
